Luliconazole Cream Suppliers & Bulk Manufacturers
Available Forms: Cream
Available Strengths: 1%
Reference Brands: Luzu (US)
Category:
Derma Drugs
Luliconazole cream is an antifungal that inhibits ergosterol synthesis in fungal cell membranes, leading to cell death. It provides rapid, effective treatment for dermatophyte and fungal skin infections, reducing symptoms like itching, redness, and scaling. Benefits include quick relief and improved skin healing when used as directed.
Luliconazole Cream is available in Cream
and strengths such as 1%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Luliconazole Cream is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Luliconazole Cream can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Luliconazole cream is approved in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical evaluation, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These products undergo validation, stability testing, and manufacturing audits. Proper documentation includes safety profiles, clinical trial data, and quality control measures. For detailed licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees the availability of safe, effective antifungal treatments for dermatophyte infections worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing